Inventor

Peter Lewandrowski

Inventor
Hirschau, DE

Overview

22→
Patents
2011–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides17%
C12NMicroorganisms or enzymes15%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture11%
C07HSugars3%
Y10TTechnical subjects covered by former us classification2%
PatentTitleYear
11,077,171Immunotherapy against several tumors including gastrointestinal and gastric cancer202110,933,118Immunotherapy against several tumors including gastrointestinal and gastric cancer202110,905,741Immunotherapy against several tumors including gastrointestinal and gastric cancer202110,898,546Immunotherapy against several tumors including gastrointestinal and gastric cancer202110,478,471Immunotherapy against several tumors including gastrointestinal and gastric cancer201910,434,136Powerful MHC-class II peptides derived from survivin201910,420,816Immunotherapy against several tumors including gastrointestinal and gastric cancer201910,357,540Immunotherapy against several tumors including gastrointestinal and gastric cancer201910,159,725Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers201810,064,913Immunotherapy against several tumors including gastrointestinal and gastric cancer20189,993,523Immunotherapy against several tumors including gastrointestinal and gastric cancer20189,895,415'Immunotherapy against several tumors including gastrointestinal and gastric cancer'20189,717,774'Immunotherapy against several tumors including gastrointestinal and gastric cancer'20179,498,512'Powerful MHC-class II peptides derived from survivin'20169,289,478'Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccine'20169,283,267'Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccines'20169,132,177'Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers'20159,101,585'Immunotherapy against several tumors including gastrointestinal and gastric cancer'20159,023,804'HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof'20159,023,802'HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof'20158,647,629'Powerful MHC-class II peptides derived from survivin'20147,994,276'Composition of tumour-associated peptides and related anti-cancer vaccine'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2021Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (22)· patent assignee history
2011–2021Based in Hirschau, DE· patent location history
2014–2018Patents assigned to LEWANDROWSKI PETER (10)· patent assignee history
2014–2018Patents assigned to WEINSCHENK TONI (8)· patent assignee history
2014–2016Based in Unterjesingen, DE· patent location history
2015–2018Patents assigned to FRITSCHE JENS (4)· patent assignee history
2015–2018Patents assigned to SINGH HARPREET (4)· patent assignee history
2015Based in Tuenbingen-Hirschau, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IMMATICS BIOTECHNOLOGIES GMBH222011–2021
LEWANDROWSKI PETERself102014–2018
WEINSCHENK TONI82014–2018
FRITSCHE JENS42015–2018
SINGH HARPREET42015–2018
Locations
LocationPatentsSpan
Hirschau, DE172011–2021
Unterjesingen, DE42014–2016
Tuenbingen-Hirschau, DE12015